Rheumatology and immunology research最新文献

Systemic sclerosis-associated interstitial lung disease: How to manage in 2024? 系统性硬化症相关间质性肺病：2024 年如何管理？

Rheumatology and immunology research Pub Date : 2024-10-21 eCollection Date: 2024-09-01 DOI: 10.2478/rir-2024-0022

Rocio Bautista-Sanchez, Dinesh Khanna

{"title":"Systemic sclerosis-associated interstitial lung disease: How to manage in 2024?","authors":"Rocio Bautista-Sanchez, Dinesh Khanna","doi":"10.2478/rir-2024-0022","DOIUrl":"https://doi.org/10.2478/rir-2024-0022","url":null,"abstract":"Systemic sclerosis (SSc) or scleroderma is an autoimmune disease characterized by immune dysregulation which leads to progressive fibrosis of the skin and internal organs. Interstitial lung disease (ILD) is present in approximately 65% of patients with SSc and it accounts for approximately 40% of all SSc deaths. Risk factors associated with the development of systemic sclerosis related interstitial lung disease (SSc-ILD) include male sex, African heritage, high modified Rodnan skin score (mRSS), presence of anti-Scl-70/Topoisomerase I antibodies, and nucleolar pattern on antinuclear antibody (ANA). The primary tool to diagnose ILD in patients with SSc is high-resolution computed tomography (HRCT). Full pulmonary function tests (PFTs) with diffusing capacity of the lungs for carbon monoxide (DLco) and ambulatory desaturation testing should be obtained following the diagnosis of SSc-ILD for disease monitoring. The purpose of this review is to provide an updated guide for the management of SSc-ILD. Our proposed first line treatment for SSc-ILD is immunosuppressive therapy such as mycophenolate mofetil, tocilizumab, and rituximab which are discussed in depth, and we present the evidence-based data that has justified the use of these pharmacotherapies. Other immunosuppressive treatments are also reviewed, and we discuss the role of antifibrotic therapy. Finally, we dive into other avenues of treatments such as chimeric antigen receptor (CAR)-T cell therapy and hematopoietic stem cell transplant.","PeriodicalId":74736,"journal":{"name":"Rheumatology and immunology research","volume":"5 3","pages":"157-165"},"PeriodicalIF":0.0,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11492822/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

MIP-C: A new autoimmune rheumatic disease concomitant with the COVID-19 pandemic. MIP-C：一种与 COVID-19 大流行同时出现的新型自身免疫性风湿病。

Rheumatology and immunology research Pub Date : 2024-10-21 eCollection Date: 2024-09-01 DOI: 10.2478/rir-2024-0018

Katja Brion, Mia Phillips, Antonio La Cava

引用次数: 0

High resolution computed tomography in systemic sclerosis: From diagnosis to follow-up. 系统性硬化症的高分辨率计算机断层扫描：从诊断到随访。

Rheumatology and immunology research Pub Date : 2024-10-21 eCollection Date: 2024-09-01 DOI: 10.2478/rir-2024-0023

Roberta Eufrasia Ledda, Corrado Campochiaro

{"title":"High resolution computed tomography in systemic sclerosis: From diagnosis to follow-up.","authors":"Roberta Eufrasia Ledda, Corrado Campochiaro","doi":"10.2478/rir-2024-0023","DOIUrl":"https://doi.org/10.2478/rir-2024-0023","url":null,"abstract":"Early diagnosis of interstitial lung disease (ILD) and pulmonary hypertension (PH) is crucial in systemic sclerosis (SSc) for both management and treatment. However, diagnosing SSc-ILD can be challenging because symptoms of lung involvement are often non-specific at the early stages of disease. High-resolution computed tomography (HRCT) of the chest is recognized as the most accurate imaging modality for baseline and follow-up evaluation of SSc-ILD. Key features of SSc-ILD on HRCT include a non-specific interstitial pneumonia (NSIP) pattern, with peripheral ground-glass opacities and extensive traction bronchiectasis. Less common HRCT manifestations include usual interstitial pneumonia (UIP) pattern, followed by diffuse alveolar damage (DAD), diffuse alveolar hemorrhage (DAH) and organizing pneumonia (OP). The extent of disease on HRCT is known to relate with prognosis and serial assessments can be helpful in monitoring disease progression or treatment response. We discuss the main chest computed tomography (CT) manifestations of SSc, highlighting the role of imaging at both baseline and follow-up evaluations.","PeriodicalId":74736,"journal":{"name":"Rheumatology and immunology research","volume":"5 3","pages":"166-174"},"PeriodicalIF":0.0,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11492825/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Extracellular vesicles and interstitial lung disease in systemic sclerosis: State of the art! 细胞外囊泡与系统性硬化症的间质性肺病：最新进展！

Rheumatology and immunology research Pub Date : 2024-10-21 eCollection Date: 2024-09-01 DOI: 10.2478/rir-2024-0019

Jelena Colic, Corrado Campochiaro, Marco Matucci-Cerinic

引用次数: 0

Pathogenesis of interstitial lung disease in systemic sclerosis. 系统性硬化症间质性肺病的发病机制。

Rheumatology and immunology research Pub Date : 2024-10-21 eCollection Date: 2024-09-01 DOI: 10.2478/rir-2024-0020

Nina Goldman, Voon H Ong, Christopher P Denton

{"title":"Pathogenesis of interstitial lung disease in systemic sclerosis.","authors":"Nina Goldman, Voon H Ong, Christopher P Denton","doi":"10.2478/rir-2024-0020","DOIUrl":"https://doi.org/10.2478/rir-2024-0020","url":null,"abstract":"Interstitial lung disease (ILD) is a frequent important complication of systemic sclerosis (SSc). Factors relevant to aetiopathogenesis of SSc are also central to SSc-ILD. Severity of SSc-ILD is variable but it has a major impact on morbidity and mortality. Factors determining SSc-ILD susceptibility reflect the genetic architecture of SSc and are increasingly being defined. There are aspects linked to immunogenomics and non-immunological genetic factors that may be less conserved and underlie some of the geographical and racial diversity of SSc. These associations may also underlie important links between autoantibody subgroups and patient level risk of SSc-ILD. Examination of blood and tissue samples and observational clinical research together with integrated analysis of in vitro and in vivo preclinical models have elucidated pathogenic mechanisms of SSc-ILD. These have confirmed the potential importance of immune mechanisms in the innate and adaptive immune systemic as well as a significant role for profibrotic pathways especially transforming growth factor beta (TGFbeta) and its regulators and downstream mediators. Recent analysis of clinical trial cohorts as well as integrated and multilevel high dimensional analysis of bio-samples has shed further light on SSc-ILD. This is likely to underpin future advances in stratified and precision medicine for treatment of SSc.","PeriodicalId":74736,"journal":{"name":"Rheumatology and immunology research","volume":"5 3","pages":"141-151"},"PeriodicalIF":0.0,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11492824/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Twists and turns: The whirl sign in a patient with systemic sclerosis. 迂回曲折：一名系统性硬化症患者的漩涡征。

Rheumatology and immunology research Pub Date : 2024-10-21 eCollection Date: 2024-09-01 DOI: 10.2478/rir-2024-0025

Lin Qiao, Dong Xu

引用次数: 0

Blau syndrome mimics Takayasu's arteritis: Report of 2 cases with literature review. 布劳综合征模仿高安氏动脉炎：2例病例报告及文献综述

Rheumatology and immunology research Pub Date : 2024-10-21 eCollection Date: 2024-09-01 DOI: 10.2478/rir-2024-0024

Xin Ma, Bei Zhang, Wenjing Wang, Lindi Jiang, Xiaofei Shi

引用次数: 0

Fibroblast activation protein inhibitor PET/CT as an emerging diagnostic modality in interstitial lung disease and other fibrotic conditions. 成纤维细胞活化蛋白抑制剂 PET/CT 作为间质性肺病和其他纤维化病症的一种新兴诊断方式。

Rheumatology and immunology research Pub Date : 2024-10-21 eCollection Date: 2024-09-01 DOI: 10.2478/rir-2024-0021

Mihai Tudor Albu, Alexandru-Emil Matei, Jörg H W Distler, Frederik L Giesel, Yuriko Mori

{"title":"Fibroblast activation protein inhibitor PET/CT as an emerging diagnostic modality in interstitial lung disease and other fibrotic conditions.","authors":"Mihai Tudor Albu, Alexandru-Emil Matei, Jörg H W Distler, Frederik L Giesel, Yuriko Mori","doi":"10.2478/rir-2024-0021","DOIUrl":"https://doi.org/10.2478/rir-2024-0021","url":null,"abstract":"Interstitial lung diseases (ILD) encompass a wide range of disorders characterized by alveolar inflammation and fibrotic tissue remodeling, marked by significant morbidity and mortality. Systemic sclerosis (SSc), among other connective tissue diseases, is a frequent cause of ILD. Assessment of pulmonary fibrosis is frequently constrained by the delayed manifestations of profibrotic activation of fibroblasts, which results in late macroscopic alterations detectable by standard imaging techniques such as computed tomography (CT) and magnetic resonance imaging (MRI) scans. 68Ga-labeled fibroblast activation protein inhibitors (68Ga-FAPI [fibroblast activation protein inhibitor]) are novel radionuclides used in the selective positron emission tomography/computed tomography (PET/CT) detection of profibrotic fibroblasts, a key player in fibrotic tissue remodeling. Application of 68Ga-FAPI in different target organs undergoing fibrosis, such as lung and heart, highlights its efficacy in detecting ongoing fibrotic processes, since FAPI tracer uptake has been correlated with clinical disease progression markers in SSc-ILD. This feature could enable physicians to detect subclinical fibrotic activity and tailor an individualised therapy plan on a case by case basis. The use of 68Ga-FAPI in ILD and other fibrotic conditions may emerge as a novel tool in future clinical practice for both activity monitoring and treatment optimisation. Other tracers tested in ILD of different etiologies have shown promising results and may in future also be considered for potential application in SSc-ILD.","PeriodicalId":74736,"journal":{"name":"Rheumatology and immunology research","volume":"5 3","pages":"152-156"},"PeriodicalIF":0.0,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11492823/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Cardiac magnetic resonance imaging in systemic sclerosis: Heart involvement in high-resolution. 系统性硬化症的心脏磁共振成像：高分辨率下的心脏受累。

Rheumatology and immunology research Pub Date : 2024-07-15 eCollection Date: 2024-06-01 DOI: 10.1515/rir-2024-0011

Jessica L Fairley, Rachael O'Rourke, Rajesh Puranik, Mandana Nikpour

引用次数: 0

Biomarkers in the evaluation of cardiac involvement in systemic sclerosis. 评估系统性硬化症心脏受累情况的生物标志物。

Rheumatology and immunology research Pub Date : 2024-07-15 eCollection Date: 2024-06-01 DOI: 10.1515/rir-2024-0013

Mohamad Fadhli Bin Masri, Sue-Ann Ng, Calvin Wl Chin, Andrea Hl Low

{"title":"Biomarkers in the evaluation of cardiac involvement in systemic sclerosis.","authors":"Mohamad Fadhli Bin Masri, Sue-Ann Ng, Calvin Wl Chin, Andrea Hl Low","doi":"10.1515/rir-2024-0013","DOIUrl":"10.1515/rir-2024-0013","url":null,"abstract":"Systemic sclerosis is a multisystemic disease for which the heart can be affected leading to cardiac complications and mortality. Up to 80% of patients with systemic sclerosis have cardiac involvement with varying levels of severity. Several molecules have been identified that can be used as markers of cardiac involvement. These biomarkers can arise directly from the heart due to cardiac damage from the disease such as cardiac troponins or from the underlying dysregulated immune process itself such as the proinflammatory cytokines including interleukin (IL)-6. This review aims to summarize the evidence on currently known biomarkers that are can be diagnostic, prognostic or predictive of primary cardiac involvement in systemic sclerosis. We also highlight potential new biomarkers based on the current understanding of the disease process. Clinical use of these markers can benefit patients through earlier identification of those with cardiac involvement, many of whom can be asymptomatic in the early stage, with higher risk of complications, with the overall goal to improve outcomes of these affected patients.","PeriodicalId":74736,"journal":{"name":"Rheumatology and immunology research","volume":"5 2","pages":"99-106"},"PeriodicalIF":0.0,"publicationDate":"2024-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11248559/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141629525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0